352665-38-4 Usage
Type of compound
Ester derivative
Parent compound
1,5-Imidazolidinedicarboxylic acid
Structural features
2-oxo group
tert-butyl (1,1-dimethylethyl) group
phenylmethyl group
Chirality
(5R)configuration
Potential applications
pharmaceutical properties
antimicrobial effects
anti-inflammatory effects
Fields of interest
organic synthesis
medicinal chemistry
Research status
Further research needed to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 352665-38-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,2,6,6 and 5 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 352665-38:
(8*3)+(7*5)+(6*2)+(5*6)+(4*6)+(3*5)+(2*3)+(1*8)=154
154 % 10 = 4
So 352665-38-4 is a valid CAS Registry Number.
352665-38-4Relevant academic research and scientific papers
Roos, Gregory H.P.,Balasubrarnaniam, Sundari,Doyle, Michael P.,Raab, Conrad E.
, p. 2165 - 2175 (1996)
A general, high yielding route to optically pure alkyl 1 N-alkyl and 1 N-acyl substituted imidazolidin-2-one-4(S)-carboxylates, with diverse potential uses in asymmetric synthesis, is reported.
PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
-
, (2013/04/13)
The present invention provides a pyrazole compound of the following general Formula [1b] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use wherein each symbol is the same as defined in the description
